1. Home
  2. STEL vs ANAB Comparison

STEL vs ANAB Comparison

Compare STEL & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stellar Bancorp Inc.

STEL

Stellar Bancorp Inc.

HOLD

Current Price

$31.43

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$43.81

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEL
ANAB
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.4B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
STEL
ANAB
Price
$31.43
$43.81
Analyst Decision
Hold
Buy
Analyst Count
3
11
Target Price
$31.33
$59.90
AVG Volume (30 Days)
270.3K
407.6K
Earning Date
01-30-2026
11-04-2025
Dividend Yield
1.90%
N/A
EPS Growth
N/A
N/A
EPS
1.94
N/A
Revenue
$416,539,000.00
$169,467,000.00
Revenue This Year
N/A
$135.45
Revenue Next Year
$3.41
N/A
P/E Ratio
$16.28
N/A
Revenue Growth
N/A
196.42
52 Week Low
$24.13
$12.21
52 Week High
$32.74
$52.47

Technical Indicators

Market Signals
Indicator
STEL
ANAB
Relative Strength Index (RSI) 50.47 45.58
Support Level $30.09 $46.89
Resistance Level $31.66 $52.47
Average True Range (ATR) 0.62 2.25
MACD -0.09 -0.96
Stochastic Oscillator 48.59 16.95

Price Performance

Historical Comparison
STEL
ANAB

About STEL Stellar Bancorp Inc.

Stellar Bancorp Inc is a U.S. based bank holding company. Through its subsidiary, Stellar Bank, the company provides a diversified range of commercial banking services predominantly to small to medium sized businesses, professionals, and individual customers. Its offerings include different types of loans, such as mortgage loans, home equity loans, automobile loans, etc.; deposit products, such as checking accounts, commercial accounts, money market accounts, savings accounts, etc.; and other banking services like mobile banking, debit cards, cash management and wire transfer services, letters of credit, and others.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: